PatientsVille.com Logo

Pulmonary and Cialis

PatientsVille

Pulmonary Symptoms and Causes

Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It is a serious condition. If you have it, the blood vessels that carry blood from your heart to your lungs become hard and narrow. Your heart has to work harder to pump the blood through. Over time, your heart weakens and cannot do its job and you can develop heart failure.

Symptoms of PH include

  • Shortness of breath during routine activity, such as climbing two flights of stairs
  • Tiredness
  • Chest pain
  • A racing heartbeat
  • Pain on the upper right side of the abdomen
  • Decreased appetite

As PH worsens, you may find it hard to do any physical activities.

There are two main kinds of PH. One runs in families or appears for no known reason. The other kind is related to another condition, usually heart or lung disease.

There is no cure for PH. Treatments can control symptoms. They involve treating the heart or lung disease, medicines, oxygen, and sometimes lung transplantation.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for pulmonary

pulmonary treatment research studies

Cialis clinical trials, surveys and public health registries


Find Drug Side Effect reports



Cialis Side Effects

Therapeutic Response Decreased (398)
Headache (367)
Vision Blurred (286)
Back Pain (260)
Myalgia (150)
Flushing (130)
Pain In Extremity (123)
Dizziness (121)
Visual Impairment (113)
Visual Acuity Reduced (111)
Optic Ischaemic Neuropathy (97)
Nasal Congestion (96)
Dyspepsia (92)
Visual Disturbance (88)
Nausea (85)
Insomnia (84)
Tinnitus (83)
Muscle Spasms (80)
Hypertension (76)
Arthralgia (67)
Visual Field Defect (48)
Erectile Dysfunction (47)
Loss Of Consciousness (46)
Gastrooesophageal Reflux Disease (42)
Asthenia (42)
Chest Pain (41)
Myocardial Infarction (41)
Pain (38)
Death (38)
Fatigue (38)
Ocular Hyperaemia (37)
Atrial Fibrillation (36)
Diarrhoea (34)
Dyspnoea (34)
Malaise (34)
Off Label Use (33)
Feeling Abnormal (31)
Blood Cholesterol Increased (31)
Cerebrovascular Accident (31)
Eye Pain (30)
Fall (30)
Hypotension (30)
Palpitations (30)
Priapism (29)
Blood Pressure Increased (28)
Diplopia (28)
Anxiety (27)
Eye Disorder (27)
Vomiting (27)
Prostate Cancer (27)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I was having frequent leg cramps. They worked their way from my foot up to my thigh. I just thought it was from stopping the use of muscle relaxers ( for a serious back and neck problem). I had forgotten about them and never mentioned it to either

My father is suffrering from idiotypic Pulmonary Fibrosis. In medication he is taking Prednisone,Perfenodone and azathropine. he is now geeting bleeding from his nose.Can anybody inform me that this is just a side effect of any d

After being discharged from eER I saw in my file that the doppler impression shows mild tricuspid regurgitation and mild pulmonary hypertension =-O scared should I be worried

After taking Cialis I experienced nause and chest discomfort for two days so far, along with a pronounced feeling of general malaise and fatigue.

Cialis works for me. I like the product and I plan to get more at www.medsheaven.com

Have u tried N-acetyltene (600mg- 3 times a day) iinstead of perfenodone. what dosage is azathropine (use 50mg/ daily). there are no side effects from N-acetyltene. also very cheap to get. perfonodone is no more better than a placebo. not

How long can one live with the diagnosis of pulmonary hypertension? I have seen 3 to 5 years but I have had it for well over 10.

I get ankle swelling (peripheral edema ) ,nasal congestion, some facial redness for a while. but man, does it work. the swelling is a pain though.

I have Pulmonary Diagnois confirmed by lung biopsy in Feb 2010. I have 100% Blockage of the LAD artery with evenly distributed atherosclerosis throughout my circulatoy system. The 100% blockage was diagnosed by heart cath in Aug of 2010.

I have taken 20mg doses of cialis 8 times, and have vomited 4 times within hours and have experienced nausea after all of them. I tend to find the drug SIGNIFICANTLY speeds up my heart rate to a worrying speed while any form of sexual contact sends i

My father is suffrering from idiotypic Pulmonary Fibrosis. In medication he is taking Prednisone,Perfenodone and azathropine. he is now geeting bleeding from his nose.Can anybody inform me that this is just a side effect of any d

After being discharged from eER I saw in my file that the doppler impression shows mild tricuspid regurgitation and mild pulmonary hypertension =-O scared should I be worried

Completed course of interferon and ribavirn for Hepititis C. Fell pregnant 5 months after completion of treatment and gave birth to a baby boy weighing 7.6 lbs. He has Trisomy 21. He was born with Persisitant Pulmonary hypertension and a VSD. I do no

Female 39 years old from Denmark. Was treated with Octostim as a test. After drug was administred i experience this: <span style='font-weight: bold;'><a href='http://sideeffects101.com/drug-side-effects/o/octostim-pulmonary-oedema.htm' rel='

Has any one found legal representation willing to pursue pulmonary embolis caused by avandia

Having suffered 3 dvt's, 1 pulmonary embolism, 1 stroke and 2 tis's, I was given Fragmin. I previously had been taking warfarin for about 20 yrs, this ceased to work. I am now told that I have Osteoporosis... I seem to remember along the way that

Hello, im using trabectedin in a few weeks, after using ifoosfamide+doxorrubicin to treat pulmonary methastasis or a synovial sarcoma i am concened about loosin my hair again because it means too much for a woman and is not easy to use a wig in summ

How long can one live with the diagnosis of pulmonary hypertension? I have seen 3 to 5 years but I have had it for well over 10.

Husband has been taking avodart for 3 years. Developed a tightness in lungs, dry, non-productive cough, lungs feel a burning sensation. Thorough heart echo tests done, stress test. chest x-ray, mri, blood work, pulmonary function tests all passed.

I am 55 years old and developed what was misdiagnosed as plantar fasciitis. I was prescribed Arhtrotec then developedinterstitial lung disease and traction bronchiectasis. NEVER aHISTORY ofpulmonary disease.Still very il

Pulmonary Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: Pulmonary Rehabilitation
Outcome Measures: Peak VO2;   6 min walk test;   Echocardiography Parameters;   Blood tests;   Medical Research Council (MRC) dyspnea score questionnaire;   St George's Respiratory Questionnaire (SGRQ) for evaluation quality of life;   International Physical Activity Questionnaire (IPAQ)- for estimation physical activity level;   Battery of 4 functional tests;   Pulmonary function test
2 Recruiting Trans-Pulmonary Biomarkers in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention:
Outcome Measures: Differences in Pulmonary Hypertension biomarkers in patients evaluated for Pulmonary Hypertension;   Vasodilator-induced changes in Pulmonary Vascular Resistance (PVR);   Vasodilator-induced changes in Pulmonary Hypertension biomarkers
3 Unknown  Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Iloprost inhalation
Outcome Measures: Safety;   Pulmonary arterial pressure;   Exercise capacity (6 minute walking test);   6 minute walking test: Min. oxygen saturation.;   NYHA class,;   Quality of life (St. George Respiratory questionnaires);   Pulmonary vascular resistance, cardiac output.;   Increment of Pulmonary arterial pressure after the exercise;   6) Pulmonary function test
4 Recruiting Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD
Condition: Chronic Obstructive Pulmonary Disease COPD
Intervention: Other: Extensive Pulmonary Rehabilitation Program
Outcome Measures: Change in Objective Cognitive functioning;   Change in Mood and Anxiety;   Change in Quality of Life;   Change in 6 Minute Walking distance Test(6-MWT);   Change in Subjective Cognitive Functioning;   Adherence to Pulmonary rehabilitation;   Change in Fatigue;   Dropout from Pulmonary rehabilitation
5 Recruiting Lung Ultrasound in Pleuritic Chest Pain
Conditions: Community Acquired Pneumonia;   Pleuritis;   Pulmonary Embolism;   Lung Cancer
Intervention: Procedure: Lung ultrasound
Outcome Measures: Sensitivity and specificity of lung ultrasound in pneumonia, chest wall pain, lung cancer, Pulmonary embolism or other causes in patients presenting with pleuritic chest pain.;   Accuracy of ultrasound in distinguishing lung consolidation in pneumonia, atelectasis, Pulmonary infarction or tumors
6 Recruiting Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
Conditions: Cachexia;   Fatigue;   Pulmonary Complications;   Radiation Toxicity;   Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Behavioral: exercise intervention;   Procedure: Pulmonary complications management/prevention;   Procedure: quality-of-life assessment;   Other: questionnaire administration
Outcome Measures: Percent improvement in the 6 minute walk from prior to post PR;   Percent improvement in the St. George Respiratory Questionnaire (SGRQ) score;   Feasibility of the program, based on number of patients attending the sessions throughout the 8 weeks
7 Not yet recruiting Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
Condition: Pulmonary Arterial Hypertension With Congenital Cardiac Shunt
Intervention: Other: Pharmacological test of Pulmonary endothelial
Outcome Measures: Predictive performance of the reactivity test to the occurence of Pulmonary arterial hypertension one year after the closure of the shunt.;   occurrence of Pulmonary hypertension.;   Nature and frequency of adverse events;   Characteristic of the distribution of test of reactivity in the population "shunt unclosed"
8 Unknown  Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease?
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Pulmonary daoyin therapy of China;   Other: usual care
Outcome Measures: 6 Minutes Walking Distance Test ( 6MWD);   Forced expiratory volume in one second, FEV1;   Modified Medical Research Council (MMRC) scale;   Quality of life
9 Unknown  Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Nonspecific Interstitial Pneumonia
Interventions: Drug: Bosentan;   Drug: Placebo
Outcome Measures: The primary endpoint is a fall in Pulmonary vascular resistance (PVR) of 20% over 16 weeks.;   mean Pulmonary arterial Pressure;   Six minute walk distance;   Quality of life scores (Camphor questionnaire);   Pulmonary function (DLco, FVC and PaO2);   Pulmonary blood flow;   Right ventricular mass (Cardiac MRI);   BNP;   Progression free survival
10 Recruiting Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: rhGM-CSF;   Procedure: Whole Lung Lavage(WLL)
Outcome Measures: Improvements in double Pulmonary diffuse lesions (Chest CT score );   Clinical symptoms observation: shod of breath, cough (according to each score standard);   Granulocyte Macrophage Colony Stimulating Factor(GM-CSF) Antibody titer change;   Improvements in Pulmonary function;   Improvements in arterial blood gas, including alveolar-arterial oxygen difference(A-aDO2), partial pressure of oxygen(PaO2), partial pressure of carbon dioxide in artery(PaCO2), arterial oxygen saturation(SaO2).
11 Not yet recruiting The Value of Bronchoscopic Lung Volume Reduction by Endobronchial Valves in Patients With Single Lung Transplantation and Overinflation of the Native Lung
Condition: Native Lung Overinflation in Patients That Underwent Single Lung Transplantation Due to Emphysema
Intervention: Device: lung volume reduction using the Zephyr device
Outcome Measures: •Mean % change in lung function (FEV1);   Mean change in six minutes walk distance
12 Recruiting Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Home-based Pulmonary rehabilitation;   Behavioral: Hospital-based Pulmonary rehabilitation
Outcome Measures: Change in 6-minute walk test;   Change in Chronic Respiratory Disease Questionnaire;   Change in Modified Medical Research Council Scale;   Cost-effectiveness;   SF-36 v2;   Program completion rate
13 Recruiting Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
Condition: High Risk of Developing Lung Cancer
Interventions: Radiation: CT scan & Early CDT Lung test;   Other: CT scan & Early CDT Lung test
Outcome Measures: CT alone vs. both Early CDT-Lung test and CT scan.;   Value of Early CDT-lung test in detecting cancer
14 Recruiting Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency
Interventions: Procedure: Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™;   Device: STEEN Solution™
Outcome Measures: 30 Day Mortality and Graft Survival;   Primary Lung Graft Dysfunction (PGD);   ICU Length of Stay;   Day 7 Ventilator/ECMO Status;   Recipient mortality at 12 months.;   Bronchiolitis Obliterans Syndrome (BOS) free graft survival.
15 Recruiting Prevention and Treatment of Immersion Pulmonary Edema
Conditions: Immersion Pulmonary Edema (IPE);   Swimming Induced Pulmonary Edema (SIPE)
Intervention: Drug: Sildenafil
Outcome Measure: Pulmonary artery pressure during cold water immersion
16 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung
Conditions: Lung Neoplasms;   Lung Transplantation
Intervention: Device: probe based laser endomicroscopy (pCLE)
Outcome Measures: Development of criteria for the characterization of discrete lung lesions and for characterization of acute lung rejection in lung transplant.;   Diagnostic performance of the pCLE image interpretation criteria for discrete lung lesions and for acute lung rejection in lung transplant.
17 Not yet recruiting Role of Lung Ultrasound and Pulsed-wave Doppler in Lung Consolidations in Mechanically Ventilated Patients
Conditions: Atelectasis;   Pneumonia
Interventions: Other: Lung ultrasound and Doppler (Day 0);   Other: Lung ultrasound and Doppler (Day 0 and Day 3 to 5)
Outcome Measures: RAcT in lung consolidations;   Temporal evolution of the RAcT;   Presence of visible blood vessels in lung consolidations;   Presence of dynamic air bronchograms in lung consolidations;   Presence of sub-pleural consolidations
18 Unknown  Pulmonary Rehabilitation and Inspiratory Muscle Training (IMT) for Patients Following Lung Transplantation
Condition: Lung Transplantation
Interventions: Behavioral: Conventional or regular Pulmonary rehabilitation program alone;   Device: very low load IMT (sham IMT) alone;   Device: Conventional or regular Pulmonary rehabilitation program + targeted inspiratory resistive or threshold IMT;   Device: Targeted inspiratory resistive or threshold IMT alone
Outcome Measures: maximal exercise capacity;   Lung function (FEV1, FVC)
19 Recruiting Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease
Conditions: Lung Cancer;   Chronic Obstructive Pulmonary Disease;   Emphysema;   Lung Surgery
Intervention: Procedure: Lung surgery
Outcome Measure: Metals/metalloids concentration
20 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Other: No specific intervention
Outcome Measures: 6 minute walk distance;   right heart catheterization hemodynamics;   chemokine peripheral blood analysis